Afinitor® (everolimus) is a drug prescribed to slow down the progression of certain types of cancers and tumors. This medicine is available as a tablet and is typically taken once daily.
Afinitor works by blocking the action of certain enzymes in the body that regulate cell function, including cell growth. By blocking these enzymes, the medication can help slow down the growth of cancer cells.
Although the medicine is generally well tolerated, it is not suitable for everyone. Before using Afinitor, make sure your healthcare provider has up-to-date information on your medical history and a list of your current medications. In particular, let your healthcare provider know if you have diabetes, a history of hepatitis B, or any problems with your kidneys or liver.
(Click Afinitor for more information on using this medication. This full-length article takes a closer look at how the drug works, potential side effects, and safety issues to be aware of while using it.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Afinitor [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation;2012 August.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed July 27, 2011.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed July 28, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click